Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person myeloma

Class:IdDisease:2328201
_displayNamemyeloma
_timestamp2012-06-25 16:56:10
created[InstanceEdit:2328203] Orlic-Milacic, M, 2012-06-25
definitionA bone marrow cancer that affects plasma cells in which abnormal plasma cells multiply uncontrollably in the bone marrow and occasionally in other parts of the body.
identifier0070004
namemyeloma
referenceDatabase[ReferenceDatabase:1247631] DOID
(disease)[EntityWithAccessionedSequence:1500706] PIK3CA E545K [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9632582] p16INK4A R58* [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9688098] RB1 N258Efs*11 [cytosol] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by myeloma (2328201)